Abstract:
The present invention relates to a method for screening substances inducing or suppressing Pin1 enzyme activation using Pin1 enzyme and, more specifically, to a method for screening substances inducing or suppressing Pin1 enzyme activation by identifying the substances inducing or suppressing Pin1 enzyme activation using enzyme-substrate reaction. According to the screening method of the present invention, effective target drugs can be selected using mass screening of the substances inducing or suppressing Pin1 enzyme activation by measuring the enzyme activation status with a simple experiment.
Abstract:
The present invention relates to a C-terminal motif of Runx family protein and a screening method of novel materials inducing stabilization of Runx family protein, more specifically, the present invention can stabilize by inhibiting maintenance of phosphorylation and ubiqutination of the Runx family protein. According to the a C-terminal motif sequence of Runx family protein and a screening method using the same, the present invention can be usefully used to develop medicines for osteodystorophy, hematogenesis disorder, and cancers by screening novel materials inducing stabilization of the Runx family protein through interaction with the Runx family protein.
Abstract:
본 발명은 Pin1 효소를 이용한 Pin1 효소의 활성화 유도 또는 억제 물질을 스크리닝하는 방법에 관한 것으로서, 보다 구체적으로는 Pin1 효소의 활성화를 유도 또는 억제하는 물질을 효소-기질 반응을 통하여 검색함으로써 Pin1 효소의 활성화 유도 또는 활성화 억제 물질을 스크리닝하는 방법에 관한 것이다. 본 발명의 스크리닝 방법에 따르면, 간단한 실험만으로 효소 활성 여부를 측정하여 Pin1 효소의 활성화 유도 또는 억제 물질을 대량으로 스크리닝함으로써 효율적인 타겟 약물의 선정이 가능하다.
Abstract:
The present invention relates to a composition for preventing or treating diseases related to malregulation in cells of runx family protein comprising Pin1 as an effective component. The composition for preventing or treating diseases related to malregulation in cells of runx family protein according to the present invention may be effectively used as a medicine for various diseases related to osteodystrophy, abnormalities of hematogenesis, and cancer.